Press release
Vesicular Stomatitis (VS) Therapeutics Market Opportunities and Forecasts, 2017 – 2025
Only symptomatic treatment with some precautionary measure are available for the disease which consists of supportive care including the prevention or treatment of secondary infections.
A Sample of this Report is Available Upon Request @ http://www.persistencemarketresearch.com/samples/16642
Vesicular Stomatitis (VS) Therapeutics Market: Drivers & Restraints
Human population growth, income growth and urbanization increases the demand of livestock products and thus the livestock population which however also increases the therapeutic products demand for animals and thus fuels the vesicular stomatitis therapeutics market. Recently in 2015, Vesicular stomatitis outbreak affected around 800 premises in 8 US states. These outbreaks are also increasing the demand for the therapeutics. Market for the vaccination of vesicular stomatitis is also high because of the unavailability of antiviral treatments. Government efforts in this direction are also the driving factors for the growth of the market. Although cases occur throughout year but occurrence of outbreaks in the US after long intervals of 5-10 years limits the therapeutic market to grow. Less research activities and product launches in this area restricts its market to expand.
Vesicular Stomatitis (VS) Therapeutics Market: Segmentation
By Treatment Type:
Symptomatic Medications
Anti-inflammatory medications
Antibiotics & Antipyretics
Antiseptic cleansing solutions
Vaccination
By Distribution Channels:
Veterinary Hospitals
Veterinary Clinics
Retail Pharmacies
By Geography
North America
Europe
Latin America
Asia-Pacific
Middle East and Africa
No specific treatment is available for the vesicular stomatitis which also creates an opportunity for the bio-pharmaceutical manufacturers to develop new and innovative drugs as to prevent the livestock economic loss. The therapeutic market is region specific as well as seasonal as the disease runs mostly from spring to fall, thus natural seasonal outbreaks are the factor for therapeutics market. Non-availability of anti-viral drugs in the market doesn’t meet the demand of the treatment.
Request to View Tables of Content @ http://www.persistencemarketresearch.com/toc/16642
A geographic condition regarding the Vesicular Stomatitis (VS) Therapeutics Market, it has been segmented into five key regions: North America, Latin America, Europe, Asia-Pacific and the Middle East & Africa. Because of regional prevalence of the disease, its therapeutic market is dominant in North America followed by Latin America. As the disease is prevalent in the tropical climates, the therapeutic market also finds an opportunity in the Asia-Pacific and African regions but very less than the western hemisphere.
Some of the players in the vesicular stomatitis therapeutic market includes Zoetis, Vedco Inc., Boehringer Ingelheim, Merck & Co., Bayer, Elanco, Ceva Santé Animale, Vibrac S.A., Vetoquinol S.A. and others.
To view complete report @http://www.persistencemarketresearch.com/market-research/vesicular-stomatitis-therapeutics-market.asp
About Us
Persistence Market Research (PMR) is a U.S.-based full-service market intelligence firm specializing in syndicated research, custom research, and consulting services. PMR boasts market research expertise across the Healthcare, Chemicals and Materials, Technology and Media, Energy and Mining, Food and Beverages, Semiconductor and Electronics, Consumer Goods, and Shipping and Transportation industries. The company draws from its multi-disciplinary capabilities and high-pedigree team of analysts to share data that precisely corresponds to clients’ business needs.
PMR stands committed to bringing more accuracy and speed to clients’ business decisions. From ready-to-purchase market research reports to customized research solutions, PMR’s engagement models are highly flexible without compromising on its deep-seated research values.
Contact
Persistence Market Research Pvt. Ltd
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
media@persistencemarketresearch.com
Web:www.persistencemarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Vesicular Stomatitis (VS) Therapeutics Market Opportunities and Forecasts, 2017 – 2025 here
News-ID: 618312 • Views: …
More Releases from Persistence Market Research
Plastic Liner Market to Reach US$ 6.67 Bn by 2030, Expanding at 4.7% CAGR - Pers …
➤ Overview of the Market
The global plastic liner market has gained steady traction across multiple industries due to its cost-effectiveness, versatility, and protective characteristics. Plastic liners are widely used in agriculture, mining, construction, waste management, and packaging industries, where they serve as an essential barrier to prevent leakage, contamination, and material loss. These liners are manufactured using materials such as polyethylene (PE), polypropylene (PP), and PVC, offering superior resistance to…
Returnable Plastic Crate Market to Reach US$ 2,665.1 Million by 2030 Fueled by S …
➤ Overview of the Market
The global returnable plastic crate market is gaining momentum as industries seek cost-effective and sustainable packaging solutions. These crates are widely used for transporting and storing perishable goods, beverages, pharmaceuticals, and industrial products due to their durability, stackability, and reusability. The shift from single-use packaging to eco-friendly alternatives has accelerated the adoption of returnable plastic crates across sectors. The market, valued at US$ 1,820.0 million in…
US Thermal Power Market Expected to Reach US$ 251.9 Mn by 2031 with 2.4% CAGR Gr …
➤Overview of the Market
The US thermal power market plays a crucial role in the nation's energy mix, serving as a stable and reliable source of electricity despite the rise of renewables. Thermal power plants in the US rely primarily on coal, natural gas, and oil to generate electricity, with natural gas emerging as the dominant fuel source due to its affordability, efficiency, and lower carbon footprint compared to coal. According…
Europe Medical Plastic Market to Reach US$ 17 Bn by 2032 Driven by Rising Health …
➤Overview of the Market
The Europe medical plastic market is undergoing robust growth, fueled by increasing demand for lightweight, durable, and cost-effective materials in the healthcare sector. Medical plastics are widely used in devices, surgical instruments, diagnostic tools, implants, and packaging due to their high biocompatibility, versatility, and resistance to sterilization methods. With healthcare systems across Europe investing heavily in modernization and patient safety, the adoption of medical-grade plastics has gained…
More Releases for Vesicular
Evolving Market Trends In The Vesicular Monoamine Transporter 2 (VMAT2) Inhibito …
We've updated all our reports with current data on tariff changes, trade developments, and supply chain shifts affecting key industries.
What Is the Expected Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor Market Size During the Forecast Period?
The market for the vesicular monoamine transporter 2 (VMAT2) inhibitor has experienced swift expansion in the recent past. The market, which was valued at $1.13 billion in 2024, is slated to reach $1.25 billion in 2025,…
Harnessing Innovation Against Vesicular Stomatitis: A New Era in Therapeutics Ma …
Vesicular Stomatitis (VS) is an acute viral disease affecting livestock, primarily cattle, horses, and swine, with sporadic outbreaks that disrupt animal health, agricultural productivity, and international trade. As biosecurity measures intensify and animal welfare becomes paramount, the market for VS therapeutics is gaining strategic importance. From antiviral compounds and immunomodulators to supportive care solutions and novel vaccine platforms, stakeholders in veterinary pharmaceuticals are charting a path toward more effective prevention…
Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor Market Set to Reach $1.85 Bi …
What market dynamics are playing a key role in accelerating the growth of the vesicular monoamine transporter 2 (vmat2) inhibitor market?
The rising prevalence of Parkinson's disease is expected to drive the growth of the vesicular monoamine transporter 2 (VMAT2) inhibitor market in the coming years. Parkinson's disease is a progressive neurological disorder that affects movement due to the loss of dopamine-producing cells in the brain. The rising prevalence of Parkinson's…
Technology Advancing at a Rapid Pace to Drive the Vesicular Stomatitis Therapeut …
Vesicular Stomatitis is a viral disease affecting the livestock population such as pigs, horses, ruminants and causes vesicles, erosions and ulcers on the udder, feet and mouth. The disease is contagious and spread via insect vectors, animal contact, and exposure to saliva or fluids. It is endemic in Southwestern and Western United States as the region have experienced a number of vesicular stomatitis outbreaks in the past decade. This results…
Vesicular Monoamine Transporter-2 Inhibitors (VMAT2 Inhibitors) Market to Regist …
Vesicular monoamine transporter 2 (VMAT2) is a membrane-embedded protein that is responsible for uptake of monoamines neurotransmitters such as dopamine, serotonin, norepinephrine, and histamines into the synaptic vesicles in monoaminergic neurons. Vesicular monoamine transporter proteins 2 are expressed in the central nervous system (CNS) and plays the crucial role in the signaling process between the monoamine neurons. VMAT2 is the only transporter that carries the cytoplasmic dopamine into the vesicles.…
Vesicular Monoamine Transporter-2 Inhibitors (VMAT2 Inhibitors) Market Analysis, …
Vesicular monoamine transporter 2 (VMAT2) is a membrane-embedded protein that is responsible for uptake of monoamines neurotransmitters such as dopamine, serotonin, norepinephrine, and histamines into the synaptic vesicles in monoaminergic neurons.
View Report-
https://www.transparencymarketresearch.com/vesicular-monoamine-transporter2-inhibitors-market.html
Vesicular monoamine transporter proteins 2 are expressed in the central nervous system (CNS) and plays the crucial role in the signaling process between the monoamine neurons. VMAT2 is the only transporter that carries the cytoplasmic dopamine into the vesicles.…
